Refractive outcomes of implantation of an implantable phakic copolymer lens with peripheral holes in the intraocular posterior chamber in moderate to high myopia patients: a single-surgeon series
Authors Subudhi P, Patro S, Khan Z, Subudhi BNR, Sitaram S
Received 16 May 2019
Accepted for publication 26 August 2019
Published 23 September 2019 Volume 2019:13 Pages 1887—1894
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 2
Editor who approved publication: Dr Scott Fraser
Praveen Subudhi,1,2 Sweta Patro,1 Zahiruddin Khan,2 B Nageswar Rao Subudhi,3 Silla Sitaram4
1Department of Cornea and Refractive Surgery, Ruby Eye Hospital, Berhampur, Odisha, India; 2Ophthalmology Department, Hitech Medical College, Bhubaneswar, India; 3Ophthalmology Department, MKCG Medical College and Hospital, Berhampur, Odisha, India; 4Ophthalmology Department, SDH, Chatrapur, Odisha, India
Correspondence: Praveen Subudhi
Ruby Eye Hospital, Govinda Vihar, Sushruta Nagar, Ganjam, Berhampur 760001, Odisha, India
Purpose: To assess the safety and efficacy of implanting implantable phakic copolymer lenses (IPCLs) with peripheral optic holes in the intraocular posterior chamber in Indian patients with moderate to high myopia.
Methods: Seventy-five eyes of 50 patients who underwent IPCL implantation were retrospectively analyzed. Preoperative parameters, such as subjective refraction, anterior chamber depth (measured using a pentacam), and white-to-white diameter were measured. A custom-made IPCL using the aforementioned parameters was then implanted in the sulcus to correct moderate to high myopia. All patients had undergone neodymium-doped yttrium aluminum garnet peripheral iridotomy.
Results: Clinical outcome data were collated retrospectively from the medical case records of the patients. The mean age was 25.36 years (standard deviation [SD]: 3.60 years), and 55.55% of the patients were men. The mean preoperative best-corrected visual acuity (BCVA) was 0.367 logmar units (SD: 0.266, max: 0.0 and min: 1.2). The post-IPCL implantation mean uncorrected visual acuity was 0.225 logmar units (SD: 0.172, max: 0 and min: 0.7), which was significantly superior to the preoperative BCVA (P=<0.0001). Forty-three patients (86%; satisfaction scores of ≥4; scale 1–5) were “highly satisfied” to “extremely satisfied” with the outcome. The mean follow-up period was 1.8 years.
Conclusion: Implantation of the IPCL with peripheral holes in the intraocular posterior chamber resulted in a clinically significant improvement in unaided visual acuity. Long-term follow-up showed optimum stability of vision.
Keywords: IPCL, pathological myopia, peripheral optical hole
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]